Joseph Philipose

Joseph Philipose has a diverse work experience spanning various roles in the pharmaceutical and healthcare industry. Joseph is currently the Senior Vice President and Chief Ethics and Compliance Officer at Emergent BioSolutions. Prior to that, they held positions at Alexion Pharmaceuticals, Inc., where they served as the Vice President of U.S. and Enterprise Compliance, as well as the Executive Director and Senior Director of various compliance programs. Joseph also worked as the U.S. Compliance Officer at Salix Pharmaceuticals and as the Director of Healthcare Advisory at PricewaterhouseCoopers. Joseph has experience in strategic planning, business development, and legal work from their roles at Kerr Health, Biogen, Pfizer, and John Peter Lee, Attorneys at Law. Joseph'sexpertise includes compliance risk assessments, FDA mandated risk management, and evaluation strategies.

Joseph Philipose has a JD degree in Law from Washington University in St. Louis School of Law. Joseph also holds a BA degree in Health and Human Services from the University at Buffalo. In terms of additional certifications, Joseph obtained a Diversity, Inclusion, and Belonging certification from LinkedIn in 2021, an Unconscious Bias certification from LinkedIn in 2021, and a Life Sciences Compliance Certification from Seton Hall School of Law in 2014.